Imprimis Secures First Key Composition Patent for Dropless Therapy ...

www.biospace.com/news_story.aspx?StoryID=471171&full=1

36 mins ago - Imprimis' Dropless Therapy® compounded antibiotic and steroid formulations ... Other than drugs compounded at a registered outsourcing facility, all Imprimis ...

FDA Unveils Ramped-up Regulatory Initiatives for Drug Compounders

FDA Unveils Ramped-up Regulatory Initiatives for Drug Compounders ...

www.jdsupra.com/legalnews/fda-unveils-ramped-up-regulatory-28010/

3 hours ago - These efforts demonstrate that FDA is continuing to actively oversee the regulation of

IA-66-40

Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs

http://www.accessdata.fda.gov/cms_ia/importalert_189.html

IA-66-41

Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.

http://www.accessdata.fda.gov/cms_ia/importalert_190.html

IA-54-16

DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS THAT ARE MARKETED AS FOODS, INCLUDING PRODUCTS MARKETED AS DIETARY SUPPLEMENTS, THAT CONTAIN AN ACTIVE PHARMACEUTICAL INGREDIENT

http://www.accessdata.fda.gov/cms_ia/importalert_1141.html